全文获取类型
收费全文 | 6436篇 |
免费 | 664篇 |
国内免费 | 227篇 |
出版年
2024年 | 20篇 |
2023年 | 162篇 |
2022年 | 230篇 |
2021年 | 330篇 |
2020年 | 293篇 |
2019年 | 315篇 |
2018年 | 248篇 |
2017年 | 197篇 |
2016年 | 215篇 |
2015年 | 269篇 |
2014年 | 442篇 |
2013年 | 570篇 |
2012年 | 334篇 |
2011年 | 351篇 |
2010年 | 247篇 |
2009年 | 257篇 |
2008年 | 276篇 |
2007年 | 333篇 |
2006年 | 250篇 |
2005年 | 250篇 |
2004年 | 201篇 |
2003年 | 176篇 |
2002年 | 137篇 |
2001年 | 79篇 |
2000年 | 90篇 |
1999年 | 84篇 |
1998年 | 93篇 |
1997年 | 43篇 |
1996年 | 81篇 |
1995年 | 52篇 |
1994年 | 52篇 |
1993年 | 72篇 |
1992年 | 60篇 |
1991年 | 47篇 |
1990年 | 33篇 |
1989年 | 39篇 |
1988年 | 32篇 |
1987年 | 38篇 |
1986年 | 41篇 |
1985年 | 44篇 |
1984年 | 48篇 |
1983年 | 46篇 |
1982年 | 41篇 |
1981年 | 24篇 |
1980年 | 27篇 |
1979年 | 19篇 |
1978年 | 5篇 |
1977年 | 8篇 |
1976年 | 6篇 |
1970年 | 4篇 |
排序方式: 共有7327条查询结果,搜索用时 15 毫秒
941.
Altered modulation of lamin A/C‐HDAC2 interaction and p21 expression during oxidative stress response in HGPS
下载免费PDF全文
![点击此处可从《Aging cell》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Elisabetta Mattioli Davide Andrenacci Cecilia Garofalo Sabino Prencipe Katia Scotlandi Daniel Remondini Davide Gentilini Anna Maria Di Blasio Sergio Valente Emanuela Scarano Lucia Cicchilitti Giulia Piaggio Antonello Mai Giovanna Lattanzi 《Aging cell》2018,17(5)
Defects in stress response are main determinants of cellular senescence and organism aging. In fibroblasts from patients affected by Hutchinson–Gilford progeria, a severe LMNA‐linked syndrome associated with bone resorption, cardiovascular disorders, and premature aging, we found altered modulation of CDKN1A, encoding p21, upon oxidative stress induction, and accumulation of senescence markers during stress recovery. In this context, we unraveled a dynamic interaction of lamin A/C with HDAC2, an histone deacetylase that regulates CDKN1A expression. In control skin fibroblasts, lamin A/C is part of a protein complex including HDAC2 and its histone substrates; protein interaction is reduced at the onset of DNA damage response and recovered after completion of DNA repair. This interplay parallels modulation of p21 expression and global histone acetylation, and it is disrupted by LMNAmutations leading to progeroid phenotypes. In fact, HGPS cells show impaired lamin A/C‐HDAC2 interplay and accumulation of p21 upon stress recovery. Collectively, these results link altered physical interaction between lamin A/C and HDAC2 to cellular and organism aging. The lamin A/C‐HDAC2 complex may be a novel therapeutic target to slow down progression of progeria symptoms. 相似文献
942.
Diane Frankel Valérie Delecourt Karim Harhouri Annachiara De Sandre‐Giovannoli Nicolas Lévy Elise Kaspi Patrice Roll 《Aging cell》2018,17(4)
Hereditary and sporadic laminopathies are caused by mutations in genes encoding lamins, their partners, or the metalloprotease ZMPSTE24/FACE1. Depending on the clinical phenotype, they are classified as tissue‐specific or systemic diseases. The latter mostly manifest with several accelerated aging features, as in Hutchinson–Gilford progeria syndrome (HGPS) and other progeroid syndromes. MicroRNAs are small noncoding RNAs described as powerful regulators of gene expression, mainly by degrading target mRNAs or by inhibiting their translation. In recent years, the role of these small RNAs has become an object of study in laminopathies using in vitro or in vivo murine models as well as cells/tissues of patients. To date, few miRNAs have been reported to exert protective effects in laminopathies, including miR‐9, which prevents progerin accumulation in HGPS neurons. The recent literature has described the potential implication of several other miRNAs in the pathophysiology of laminopathies, mostly by exerting deleterious effects. This review provides an overview of the current knowledge of the functional relevance and molecular insights of miRNAs in laminopathies. Furthermore, we discuss how these discoveries could help to better understand these diseases at the molecular level and could pave the way toward identifying new potential therapeutic targets and strategies based on miRNA modulation. 相似文献
943.
944.
Combination of resveratrol and 5‐azacytydine improves osteogenesis of metabolic syndrome mesenchymal stem cells
下载免费PDF全文
![点击此处可从《Journal of cellular and molecular medicine》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Krzysztof Marycz Katarzyna Kornicka Jennifer M. Irwin‐Houston Christine Weiss 《Journal of cellular and molecular medicine》2018,22(10):4771-4793
Endocrine disorders have become more and more frequently diagnosed in humans and animals. In horses, equine metabolic syndrome (EMS) is characterized by insulin resistance, hyperleptinemia, hyperinsulinemia, inflammation and usually by pathological obesity. Due to an increased inflammatory response in the adipose tissue, cytophysiological properties of adipose derived stem cells (ASC) have been impaired, which strongly limits their therapeutic potential. Excessive accumulation of reactive oxygen species, mitochondria deterioration and accelerated ageing of those cells affect their multipotency and restrict the effectiveness of the differentiation process. In the present study, we have treated ASC isolated from EMS individuals with a combination of 5‐azacytydine (AZA) and resveratrol (RES) in order to reverse their aged phenotype and enhance osteogenic differentiation. Using SEM and confocal microscope, cell morphology, matrix mineralization and mitochondrial dynamics were assessed. Furthermore, we investigated the expression of osteogenic‐related genes with RT‐PCR. We also investigated the role of autophagy during differentiation and silenced PARKIN expression with siRNA. Obtained results indicated that AZA/RES significantly enhanced early osteogenesis of ASC derived from EMS animals. Increased matrix mineralization, RUNX‐2, collagen type I and osteopontin levels were noted. Furthermore, we proved that AZA/RES exerts its beneficial effects by modulating autophagy and mitochondrial dynamics through PARKIN and RUNX‐2 activity. 相似文献
945.
E. M. Wachman M. J. Hayes H. Shrestha F. N. U. Nikita A. Nolin L. Hoyo K. Daigle H. E. Jones D. A. Nielsen 《Genes, Brain & Behavior》2018,17(7)
Neonatal abstinence syndrome (NAS) due to in‐utero opioid exposure has significant variability of severity. Preliminary studies have suggested that epigenetic variation within the μ‐opioid receptor (OPRM1) gene impacts NAS. We aimed to determine if DNA methylation in OPRM1 within opioid‐exposed mother‐infant dyads is associated with differences in NAS severity in an independent cohort. Full‐term opioid‐exposed newborns and their mothers (N = 68 pairs) were studied. A DNA sample was obtained and then assessed for level of DNA methylation at 20 CpG sites within the OPRM1 promoter region by next‐generation sequencing. Infants were monitored for NAS and treated with replacement opioids according to institutional protocol. The association between DNA methylation level at each CpG site with NAS outcome measures was evaluated using linear and logistic regression models. Higher methylation levels within the infants at the ?18 (11.4% vs 4.4%, P = .0001), ?14 (46.1% vs 24.0%, P = .002) and +23 (26.3% vs 12.9%, P = .008) CpG sites were associated with higher rates of infant pharmacologic treatment. Higher levels of methylation within the mothers at the ?169 (R = 0.43, P = .008), ?152 (R = 0.40, P = .002) and +84 (R = 0.44, P = .006) sites were associated point‐wise with longer infant length of stay. Maternal associations remained significant point‐wise for ?169 (β = 0.07, P = .007) and on an experiment‐wise level for +84 (β = ?0.10, P = .003) using regression models. These results suggest an association of higher levels of OPRM1 methylation at specific CpG sites and increased NAS severity, replicating prior findings. These findings have important implications for personalized treatment regimens for infants at high risk for severe NAS. 相似文献
946.
Teruo Kawada 《Bioscience, biotechnology, and biochemistry》2018,82(4):547-553
AbstractObesity is a key factor in metabolic syndrome. The study of metabolic syndrome focuses on the anti-weight gain properties of physiological mechanisms and food components. Abnormal energy metabolism is a major risk factor of metabolic syndrome. Chronic inflammation is a feature of obesity; cytokines from hypertrophied adipocytes cause inflammation in both adipose tissue and blood vessels, resulting in symptoms of metabolic syndrome. Tumor necrosis factor-α causes insulin resistance in adipocytes and regression of brown adipocytes, resulting in abnormal energy metabolism. Functional foods can serve as a strategy for prevention and treatment of obesity linked with metabolic processes in white and brown adipose tissues. Diet-induced thermogenesis caused by certain food components stimulates burning of stored fat within adipose tissues. A mechanistic understanding of dietary thermogenesis via the sympathetic nerve system will prove valuable for the development of precise strategies for the practical prevention of metabolic syndrome. 相似文献
947.
948.
Mark A. Seefeld Hong Lin Joerg Holenz Dave Downie Brian Donovan Tingting Fu Kishore Pasikanti Wei Zhen Matthew Cato Khuram W. Chaudhary Pat Brady Tania Bakshi Dwight Morrow Sridharan Rajagopal Swapan Kumar Samanta Naveena Madhyastha Bharathi Mohan Kuppusamy Robert W. Dougherty Yasuji Matsuoka 《Bioorganic & medicinal chemistry letters》2018,28(23-24):3793-3797
Neuronal voltage-gated potassium channels, KV7s, are the molecular mediators of the M current and regulate membrane excitability in the central and peripheral neuronal systems. Herein, we report novel small molecule KV7 openers that demonstrate anti-seizure activities in electroshock and pentylenetetrazol-induced seizure models without influencing Rotarod readouts in mice. The anti-seizure activity was determined to be proportional to the unbound concentration in the brain. KV7 channels are also expressed in the bladder smooth muscle (detrusor) and activation of these channels may cause localized undesired effects. Therefore, the impact of individual KV7 isoforms was investigated in human detrusor tissue using a panel of KV7 openers with distinct activity profiles among KV7 isoforms. KCNQ4 and KCNQ5 mRNA were highly expressed in detrusor tissue, yet a compound that has significantly reduced activity on homomeric KV7.4 did not reduce detrusor contraction. This may suggest that the homomeric KV7.4 channel plays a less significant role in bladder contraction and further investigation is needed. 相似文献
949.
Benjamin E. Blass Pravin Iyer Magid Abou-Gharbia Wayne E. Childers John C. Gordon Mercy Ramanjulu George Morton Premkumar Arumugam Joshodeep Boruwa John Ellingboe Sayan Mitra Rajashekar Reddy Nimmareddy Shalini Paliwal Jamallamudi Rajasekhar Savithiri Shivakumar Pratima Srivastava Raghuram S. Tangirala Konda Venkataramanaiah L. Krishnakanth Reddy 《Bioorganic & medicinal chemistry letters》2018,28(13):2270-2274
The synthesis of steroid hormones is critical to human physiology and improper regulation of either the synthesis of these key molecules or activation of the associated receptors can lead to disease states. This has led to intense interest in developing compounds capable of modulating the synthesis of steroid hormones. Compounds capable of inhibiting Cyp19 (Aromatase), a key enzyme in the synthesis of estrogens, have been successfully employed as breast cancer therapies, while inhibitors of Cyp17 (17α-hydroxylase-17,20-lyase), a key enzyme in the synthesis of glucocorticoids, mineralocorticoids and steroidal sex hormones, are a key component of prostate cancer therapy. Inhibition of CYP17 has also been suggested as a possible target for the treatment of Cushing Syndrome and Metabolic Syndrome. We have identified two novel series of stilbene based CYP17 inhibitors and demonstrated that exemplary compounds in these series have pharmacokinetic properties consistent with orally delivered drugs. These findings suggest that compounds in these classes may be useful for the treatment of diseases and conditions associated with improper regulation of glucocorticoids synthesis and glucocorticoids receptor activation. 相似文献
950.